Karoline Laske

发表

Cryopreservation of MHC Multimers: Recommendations for Quality Assurance in Detection of Antigen Specific T Cells

S. H. van der Burg, S. Hadrup, C. Britten, 2014, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8+ T cells with detection by ELISPOT and HLA-multimer staining

S. H. van der Burg, M. Welters, P. Romero, 2014, Cancer Immunology, Immunotherapy.

Erratum to “Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient”

H. Rammensee, S. Stevanović, O. Kohlbacher, 2016, Journal of hepatology.

Development of an RNA-based kit for easy generation of TCR-engineered lymphocytes to control T-cell assay performance.

Cedrik M Britten, Marij J P Welters, Ugur Sahin, 2018, Journal of immunological methods.

Personalized peptide vaccine-induced immune response associated with long-term survival of a metastatic cholangiocarcinoma patient

Oliver Kohlbacher, Sven Nahnsen, Mathias Walzer, 2016, Journal of hepatology.

Optimization in Detection of Antigen‐Specific T Cells Through Differentially Labeled MHC Multimers

M. Welters, S. Hadrup, C. Gouttefangeas, 2019, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer

H. Rammensee, S. Stevanović, B. Pichler, 2019, Journal of Immunotherapy for Cancer.

The development of standard samples with a defined number of antigen-specific T cells to harmonize T cell assays: a proof-of-principle study

Cedrik M. Britten, Cécile Gouttefangeas, Marij J. P. Welters, 2012, Cancer Immunology, Immunotherapy.

Validation of Immunomonitoring Methods for Application in Clinical Studies: The HLA‐Peptide Multimer Staining Assay

H. Rammensee, C. Ottensmeier, C. Gouttefangeas, 2018, Cytometry. Part B, Clinical cytometry.

Results of a Phase 1/2 Study in Metastatic Renal Cell Carcinoma Patients Treated with a Patient-specific Adjuvant Multi-peptide Vaccine after Resection of Metastases.

H. Rammensee, S. Stevanović, A. Stenzl, 2017, European urology focus.

Supplementary Issue: Array Platform Modeling and Analysis (b) Managing Multi-center Flow Cytometry Data for Immune Monitoring

Cliburn Chan, Jennifer Enzor, Janet Staats, 2022 .

Alternative Variants of Human HYDIN Are Novel Cancer-Associated Antigens Recognized by Adaptive Immunity

H. Rammensee, S. Stevanović, S. Nedospasov, 2013, Cancer Immunology Research.

76 Clinical and immunological monitoring of a multi-peptide vaccination trial in patients with stage III renal cell carcinoma

H. Rammensee, S. Stevanović, A. Stenzl, 2012 .